Indication
Hypercalcemia
Hypercalcemia is a metabolic and electrolyte disorder characterized by abnormally high concentrations of calcium in the bloodstream, typically defined as a total serum calcium exceeding 10.5 mg/dL or an ionized calcium level above 5.3 mg/dL. Read more about Hypercalcemia
0 drugs 0 manufacturers
Drugs that treat it
Common Hypercalcemia therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypercalcemia is a metabolic and electrolyte disorder characterized by abnormally high concentrations of calcium in the bloodstream, typically defined as a total serum calcium exceeding 10.5 mg/dL or an ionized calcium level above 5.3 mg/dL.
It arises when the entry of calcium into the circulation exceeds urinary excretion or bone deposition, most commonly driven by primary hyperparathyroidism or malignancy-associated osteolysis and humoral factors.
The condition systemically affects the renal, gastrointestinal, neuromuscular, and cardiovascular systems.
While mild elevations may be asymptomatic, progressively higher levels lead to nephrogenic diabetes insipidus, nephrolithiasis, muscle weakness, constipation, neuropsychiatric disturbances, cardiac arrhythmias, and potentially life-threatening encephalopathy.
- nih.gov
Hypercalcemia is a metabolic and electrolyte disorder characterized by abnormally high concentrations of calcium in the bloodstream, typically defined as a total serum calcium exceeding 10.5 mg/dL or an ionized calcium level above 5.3 mg/dL
- nih.gov
It arises when the entry of calcium into the circulation exceeds urinary excretion or bone deposition, most commonly driven by primary hyperparathyroidism or malignancy-associated osteolysis and humoral factors While mild elevations may be asymptomatic, progressively higher levels lead to nephrogenic diabetes insipidus, nephrolithiasis, muscle weakness, constipation, neuropsychiatric disturbances, cardiac arrhythmias, and potentially life-threatening encephalopathy
- merckmanuals.com
It arises when the entry of calcium into the circulation exceeds urinary excretion or bone deposition, most commonly driven by primary hyperparathyroidism or malignancy-associated osteolysis and humoral factors While mild elevations may be asymptomatic, progressively higher levels lead to nephrogenic diabetes insipidus, nephrolithiasis, muscle weakness, constipation, neuropsychiatric disturbances, cardiac arrhythmias, and potentially life-threatening encephalopathy
- nih.gov
The condition systemically affects the renal, gastrointestinal, neuromuscular, and cardiovascular systems While mild elevations may be asymptomatic, progressively higher levels lead to nephrogenic diabetes insipidus, nephrolithiasis, muscle weakness, constipation, neuropsychiatric disturbances, cardiac arrhythmias, and potentially life-threatening encephalopathy
- mayoclinic.org
While mild elevations may be asymptomatic, progressively higher levels lead to nephrogenic diabetes insipidus, nephrolithiasis, muscle weakness, constipation, neuropsychiatric disturbances, cardiac arrhythmias, and potentially life-threatening encephalopathy
Personalize your experience
Follow Hypercalcemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.